ASBP
NASDAQ · Pharmaceuticals
Aspire Biopharma Holdings In
$8.71
+0.17 (+1.99%)
Open$8.87
Previous Close$8.54
Day High$8.91
Day Low$8.69
52W High$562.80
52W Low—
Volume—
Avg Volume40.4K
Market Cap12.50M
P/E Ratio—
EPS$-121.90
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 182.0K | 2.20M | 2.09M |
| Net Income | -718,912,415 | 266.8K | 312.0K |
| Profit Margin | -394,852.4% | 12.1% | 14.9% |
| EBITDA | -578,968,639 | 501.0K | 520.7K |
| Free Cash Flow | — | 197.3K | 259.9K |
| Rev Growth | — | +5.7% | +22.2% |
| Debt/Equity | 0.00 | 0.42 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |